Our Values
-
Safety & Quality
Safety and quality are a priority for Renal Services. As a company, we manage all aspects of clinical care, quality control and infection prevention at each of our clinics.
The Care Quality Commission (CQC) regulates our services and we are proud of the fact that we consistently achieve 100% compliance with the CQC requirements, year after year. -
Excellence in Patient Care
All the Renal Services clinics provide dialysis patients with efficient, effective community-based services that offer:
• Friendly, professional care to meet individual needs;
• TVs, headphones and refreshments during treatment;
• The latest medical technology for specialist therapies;
• Clean, comfortable surroundings. -
Independence
As an independent company, Renal Services is not limited to one manufacturer’s products, we can provide the most appropriate dialysis machines and latest therapeutic options to suit each patient’s needs.
By offering patients local dialysis units and holiday dialysis centres, we can also help them stay independent for longer. -
Innovation
Renal Services is at the forefront of innovation in the management of End Stage Renal Disease.
We are an early adopter of new technologies in dialysis and vascular access and we support the development of new therapies, medical devices and drugs that improve patient outcomes.
Management Team
Meet our senior management team. They guide our company in it’s quest to achieve our values and goals for Renal Services’ patients and professional staff. All our management team members have considerable experience working within the dialysis industry in the UK, Europe and the US.
Stefano Ciampolini Chief Executive Officer and Co-Founder
Stefano is Adjunct Professor of Imperial College Business School in London and Mentor for Imperial Enterprise Lab’s Venture Mentoring Service, as well as a coach at the ETH Innovation & Entrepreneurship Lab in Zurich.
Stefano is a healthcare entrepreneur and the CEO and founder of Renal Services, a UK dialysis services company. He is also managing partner and founder of Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialising in life sciences and healthcare ventures and a managing partner and founder at MedScience Ventures (Boston), a life sciences venture capital fund.
As part of his activities Stefano is a founder, board member and investor in several healthcare and medtech ventures and private equity funds focusing on healthcare investments in Europe and the US. He is founder and board member of Pure Life Renal, a US dialysis services company, a founder and board member of biofficient.com, a bio-procurement platform, a founder and board member of UV Light Care, a US medical devices company.
Stefano earned an MBA from Imperial College Business School in London in 1994 and holds a degree in economics from Kingston University in London.
Kathy Lloyd Chief Operating Officer
Kathy has worked as a renal nurse specialist since 1994 and has been involved in the development and management of dialysis centres in the UK since 1998. She has managed renal services for Total Renal Care, Fresenius Medical Care and The London Clinic. As HR Project Manager at The London Clinic, Kathy was a key specialist in the delivery of the Human Resources strategy in enabling the organisation to become the employer of choice and in securing cost savings of over £1.5m in the first year of the project.
Kathy is responsible for the delivery and management of all clinical services provided by Renal Services, incorporating human resources management and business development. She provides nursing leadership to ensure the highest level of professional practice and patient care is met.
In addition to being a qualified RN, Kathy has an MBA, BSc Honours Degree in Health Services Management and she is PRINCE 2 qualified.
Dr Neluka Weerasooriya Head of Contracts - Quality & Regulatory
Neluka has over 20 years experience in renal nursing in both public and private sector hospitals. Her academic background is in chemistry and she has a PhD in Organic Chemistry. Neluka is responsible for the co-ordination and development of clinical governance activities and for the Renal Services’ registration programme with the Care Quality Commission. She is also responsible for monitoring standards of care in all the renal units and leads on all tendering for new business.
Manjinder Dhaliwal Head of Finance
Manj is responsible for financial management at Renal Services including statutory financial statements. Prior to joining Renal Services, Manj worked at the Health Professions Council (HPC) as a Financial Accountant where she was responsible for managing public funds and cash-flows together with balance sheet management.
During her time there, she was also involved with the replacement by HPC of its predecessor, the Council for Professions Supplementary to Medicine, and recently in the transfer of the General Social Care Council to HPC. Previously she worked as a Budget Accountant for Ferns Management Consulting where she was responsible for both management and financial statements. Manj is a qualified chartered accountant and an associate member of CIMA; she holds a BA (Hons) degree from the University of Kent.
Sharon Jones Lead Nurse
Sharon is both a renal and diabetes specialist nurse with over 20years experience.During her extensive career and as lead for technology she was instrumental in setting up a new insulin pump service and developing structured education programmes for West Herts NHS Hospitals Trust.
As Lead Nurse at Renal Services, Sharon’s main focus is to continue to progress the education and professional development opportunities for nursing staff, whilst additionally working with all staff and healthcare partners to concentrate on delivering the highest quality of patient care.
The Board
Renal Services is a growing UK business and our board members are responsible for the current and future success of the company, including its overall strategic direction, financial management and governance.
James Buckley Non-Executive Chairman - Remuneration & Audit Committee Member
James has over fifteen years of experience working with healthcare companies. James’ focus is on companies with very significant growth potential either organically or through acquisition.
Previously he was CEO of Tunstall Healthcare, a world leading provider of
tele-healthcare solutions, growing sales to £150m from 2.5m customers in 30 countries and 1,200 staff globally. James has extensive experience of working in the UK social healthcare market and internationally.
Previously James worked for Cable & Wireless for over ten years, as well as other technology businesses.
Stefano Ciampolini Chief Executive Officer and Co-Founder
Stefano Ciampolini is Adjunct Professor of Imperial College Business School in London and Entrepreneur in Residence at Imperial Enterprise Lab as well as a coach at the ETH Innovation & Entrepreneurship Lab in Zurich.
Stefano is a healthcare entrepreneur and the CEO and founder of Renal Services, a UK dialysis services company. He is also managing partner and founder of Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialising in life sciences and healthcare ventures and a managing partner and founder at MedScience Ventures (Boston), a life sciences venture capital fund.
As part of his activities Stefano is a founder, board member and investor in several healthcare and medtech ventures and private equity funds focusing on healthcare investments in Europe and the US. He is founder and board member of Pure Life Renal, a US dialysis services company, a founder and board member of biofficient.com, a bio-procurement platform, a founder and board member of UV Light Care, a US medical devices company.
Stefano earned an MBA from Imperial College Business School in London in 1994 and holds a degree in economics from Kingston University in London.
Dr Patrick Carr Head of Medical Advisory Board
Dr Carr graduated in medicine from Westminster Hospital Medical School in 1984 and has been a consultant nephrologist since 1995. He is Regional Specialty Advisor in Renal Medicine for the Royal College of Physicians and has been involved in and chaired Specialty Training Committees.
He is vice-chairman of the national Specialty Advisory Committee in Renal Medicine and has special responsibility for Certification and Accreditation. He is also lead for CESR assessments to approve training of non UK trainees so that they may apply to the GMC for specialist certification.
He is a trained Clinical Safety Officer.
Over the past 24 years Dr Carr has held various clinical and management positions mostly focussed on training, information management and safety. He has published in various journals.
Scott Maguire Director and Co-Founder - Remuneration Committee Member
Mr Maguire has over 30 years of global life sciences and healthcare investment banking, management and board experience, raising well in excess of $1billion as an executive and an advisor. Mr Maguire has set up three companies and two divisions of large cap companies. Having recently been Chairman and CEO of Xenetic Biosciences Inc (XBIO), Scott turned a life science start up with a few patents into a clinical stage company listed on NASDAQ, a listing he led in 2016. He is also co-founder and board member of Renal Services UK Ltd, one of largest providers of dialysis services in the UK. In 2001 he founded Healthcare Capital Partners Ltd, a healthcare and life science corporate finance and proprietary investment boutique which has been responsible for hundreds of millions in investments and exits since its founding. In 1996 he co-founded the Arthur Andersen global healthcare corporate finance practice based in London which he assisted in building from 2 to 35 bankers globally. Scott started his banking career on Wall Street with Merrill Lynch in 1987.
George Tsangarides Remuneration & Audit Committee Member
George was appointed to the board at Renal Services as part of the investment from BGF. He sits on the remuneration and audit committees.
George joined BGF in early 2012 and is based in the London office. Covering London, Essex and Norfolk, George is responsible for identifying and completing new investment opportunities as well as continuing to work with the boards of BGF’s investee companies.
Prior to BGF, George advised a number of large cap companies in fundraising and M&A across the Telecoms, Media and Technology sectors as an investment banker at Bank of America Merrill Lynch.
He holds a MA Oxon in Politics, Philosophy and Economics from Oxford University and a MSc in Finance from the London School of Economics.
Henrik Westling Director - Audit Committee Member
Henrik graduated from Delta State University, Mississippi and Linkoping University in Sweden with BAs in Finance, Accounting and Management Control. Henrik started his professional career at Arthur Andersen in 1994, where he mainly worked in the Corporate Finance practice in London and in Stockholm. In 2002, he joined Evli Bank in Stockholm following its acquisition of Arthur Andersen’s Nordic Corporate Finance operations. Since then he has been responsible for Evli’s Healthcare Corporate Finance team with focus on healthcare M&A in Northern Europe. Henrik has project led a significant number of domestic and cross-border transactions in the healthcare industry, including several dialysis related transactions.
Yiannos Mouzouris Director
Yiannos graduated with a PhD in electrical engineering and MS in finance, investment and banking from the University of Wisconsin-Madison in 1998.
After graduation he worked for Prudential Securities Inc. in New York where he was responsible for structuring asset-backed securities, and subsequently for Tufton Oceanic in Cyprus and Dubai where he was responsible for developing fund management products and working on corporate finance transactions in the maritime sector.
He joined the Interorient Group, Cyprus, in 2005 where he is responsible for business development. He has been actively involved in several acquisitions and joint venture investments and has served on the boards of public and private companies.
Quality Assurance
DISCOVER MOREInspired Patient Care
Founded in 2007, Renal Services operates twenty one dialysis units across the UK. We aim to improve patients’ quality of life, allowing them easier access to local haemodialysis and more personal freedom.
Investors
In November 2014, Renal Services received an investment of £3.1m in growth capital from BGF (Business Growth Fund). The funding is allowing Renal Services to expand its network of dialysis centres across the UK and open new units.
Alongside its equity investment, BGF contributed additional support to the company through the introduction of James Buckley as Non-Executive Chairman. James has an extensive background in the healthcare sector, formerly as CEO of Tunstall Group until 2009 and currently as Chairman of Ark Home Healthcare and Mangar International, and Non-Executive Director of Prism Medical.
